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Structured Abstract
Objective—To evaluate the influence of the maturational stages of zygomaticomaxillary sutures 
(ZMS) on the response to maxillary protraction.
Subjects and Methods—A total of 40 Class III patients were treated retrospectively with either 
a combination of rapid maxillary expansion and facial mask (RME/FM) or bone-anchored 
maxillary protraction (BAMP). The RME/FM group consisted of 18 patients (mean age 8.3 years), 
while the BAMP group was comprised of 22 patients (mean age 11.8 years). The initial CBCT 
images (T1) of the ZMSs were classified blindly. 3D models from CBCT images at the start and at 
the end of orthopaedic treatment were registered on the anterior cranial base, and corresponding 
structures were measured on colour-coded maps and semitransparent overlays. The amounts of 
protraction of the maxilla, zygoma, orbitale and maxillary first molars for both groups were 
analysed with two-way ANOVA with Holm-Sidak post hoc test for multiple comparisons.
Results—A significant association was found between the early maturation stages of the ZMSs 
and the amount of maxillary protraction, regardless of the protraction method used. Class III 
patients with ZMS stages A and B showed greater maxillary protraction than patients at stage C.
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Conclusion—The maturational stages of ZMS are associated with the response maxillary 
protraction.
Keywords
angle class III; cranial sutures; malocclusion; maxillary retrognathia
1 | INTRODUCTION
Rapid maxillary expansion and facial mask (RME/FM) therapy typically is indicated for 
treatment of Class III malocclusion associated with maxillary skeletal retrusion.1–4 The 
effects produced by this treatment protocol include more convexity of the facial profile5 due 
to forward displacement of the maxilla,4 clockwise rotation of the mandible,5 proclination of 
the maxillary incisors6 and a counterclockwise rotation of the palatal plane.7
To produce greater skeletal effects, early RME/FM treatment has been advocated. However, 
different chronological ages have been proposed as the best timing for initiating the 
RME/FM protocol. While some authors have recommended treatment up to 8 years,8 9 
years9 and 10 years of age10,11 or before puberty,12 others did not identify any differences in 
response according to chronological age.2,13,14
Great individual variability in the amount of maxillary protraction has been demonstrated 
also in patients treated with bone-anchored maxillary protraction (BAMP).15 BAMP is 
initiated in the late mixed dentition or early permanent dentition. De Clerck and co-workers 
state that the placement of the miniplates typically should be delayed until after 10 years of 
age because the zygomatic plates tend to fail more often in younger patients.16
The amount of maxillary protraction is dependent on the maturation of the circummaxillary 
sutures, including the transverse palatine suture, the frontomaxillary sutures and the 
zygomaticomaxillary sutures (ZMSs). Kambara17 demonstrated that the ZMSs presented 
similar histological findings, or even greater complexity of interdigitations, compared to 
other circummaxillary sutures in young (mixed dentition phase) and older (permanent 
dentition phase) monkeys. The ZMSs are the longest and thickest circummaxillary 
sutures.18–20 They are oriented along the direction of the applied force system used in 
maxillary protraction.21 Individual assessment of the maturation of ZMSs, therefore, may 
represent an indicator of the response to orthopaedic maxillary protraction.
In Part 1 of this investigation,22 we presented a classification of the maturational stages of 
the ZMSs. The aim of this study was to evaluate the influence of the maturational stages of 
the ZMSs on the amount of maxillary protraction produced by RME/FM and BAMP 
protocols in growing patients with Class III malocclusion. The differences between the two 
protocols were of secondary interest because the main goal of this study was to evaluate an 
adequate sample of children who underwent maxillary protraction at the three earliest stages 
of ZMS maturation and for whom CBCT data were available.
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2 | SUBJECTS AND METHODS
The study sample was comprised of 45 Caucasian patients with Class III malocclusion 
diagnosed by a Wits appraisal of −1 mm or less, an anterior cross-bite or incisor end-to-end 
relationship and a Class III molar relationship or mesial terminal step for the deciduous 
second molars. This retrospective study was approved by the Institutional Review Board 
from the University of Michigan.
Patients were treated with either RME/FM or BAMP protocols. The RME/FM group 
consisted of 18 patients (15 females, three males) with a mean age of 8.3 years (range from 
5.6 to 10.7 years), treated consecutively by one orthodontist (C.T.H.) at the Methodist 
University of São Paulo in São Bernardo do Campo, Brazil. Rapid maxillary expansion was 
accomplished by way of a banded Hyrax expander, to which hooks were attached for 
elastics. Immediately after expansion, maxillary protraction was performed with an 
individual facial mask23 combined with extraoral elastics delivering 600 to 800 g of force 
per side. Patients were asked to wear the facial mask for 14 to 16 hours per day. The elastics 
were oriented from the expander to the facial mask in a downward and forward direction at 
an angle of 15 to 30 degrees relative to the occlusal plane.24
The BAMP group was comprised of 22 patients (12 females and 10 males) with a mean age 
of 11.8 years (range from 9.7 to 13.6 years), treated consecutively by one operator (H.D.C.), 
in a private practice in Brussels, Belgium. For the BAMP protocol, four miniplates (Bollard; 
Tita-Link, Brussels, Belgium) were inserted into the infrazygomatic crests of the maxillary 
buttress and between mandibular lateral incisors and canines. Extensions of these plates 
perforated the attached gingiva near the mucogingival junction. The initial force was 100g/
side, progressing to a maximum force of 250g/side. Patients were instructed to wear the 
elastics 24h/day. For patients who presented with an anterior cross-bite, a removable 
maxillary biteplate was placed to eliminate the occlusal interference until the overjet was 
corrected.16 Patients of both groups were treated at least to a positive overjet, with most 
patients overcorrected to a Class II molar relationship.
Both samples were analysed in a previous study in 2013.24 For the current study, two male 
and two female patients were excluded from the RME/FM group due to poor image quality 
(artefacts) in the ZMS region that did not allow a reliable evaluation of the maturational 
stage. One male patient was replaced with a female patient, as this girl started her treatment 
later than others; therefore, the final RME/FM sample consisted of 18 patients (15 females 
and three males). For the same reason, one female and two males were excluded from the 
original BAMP group as reported in 2013.24
Cone-beam computed tomography (CBCT) scans were obtained from all patients using an 
iCATTM Cone Beam 3-D Imaging System (Imaging Science International, Hatfield, PA, 
USA). Each subject was seated in an upright position with the Frankfort plane (superior 
aspect of the external auditory canal to infraorbital rim line) parallel to the floor during the 
scanning process. For all scans, the minimum field of view (FOV) used was 16×22 cm, and 
the scan time was 20–40 seconds. CBCT images were taken at the onset (T1) and after 
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approximately 10 months for the RME/FM group and after 12 months for the BAMP group 
(T2).
2.1 | Classification of the ZMSs maturation
The CBCT images of the ZMSs at T1 were analysed using Invivo5™ software (Anatomage, 
San Jose, CA, USA). Head orientation in the three planes of space and the selection of the 
slice for evaluation of the ZMSs maturation were performed according to the protocol 
described previously in the Part I of this study.22
The maturation of the ZMSs was determined in the sagittal view, at the infraorbital 
(superior) and infrazygomatic (inferior) portions of the suture. Radiographic interpretation 
was performed in the sagittal cross-sectional slice that best allowed visualization of the long 
axis of the ZMS. No adjustments in contrast or brightness of these images were performed. 
In a darkened room, the blinded ZMS samples were classified by one expert examiner 
(F.A.), according to the visual analysis method described in Part I of this study. Usually, the 
ZMSs of both sides presented the same maturational stage. Thus, for staging purpose, only 
one maturational stage of ZMSs for each patient was determined. Only two patients (one per 
group) showed different maturational stages of ZMSs on the right and left sides. For these 
cases, the more matured maturational stage of ZMSs was evaluated.
2.2 | Construction of 3D-surface models
To evaluate the forward displacement of the maxilla and zygomas promoted by facial mask 
or BAMP treatments, 3D-surface models were constructed from CBCT images of all 
patients at T1 and T2. Model construction, cranial base registration and visualization, and 
assessment of treatment outcomes were performed according to protocols described in detail 
in previous studies.16,24,25
After acquisition, the CBCT scans were reformatted to an isotropic resolution of 
0.5×0.5×0.5 mm to decrease the computational power and the time required to compute the 
automated registration. Three-dimensional surface models of the anatomic region of interest 
were constructed using ITK-SNAP (open-source software; http://www.itksnap.org). The 
initial and final 3D models were registered on anterior cranial fossa structures (3D Slicer, 
open-source software, https://www.slicer.org), specifically the endocranial surfaces of the 
cribriform plate region of the ethmoid bone and the internal surface of the frontal bone, as 
these regions had completed their growth early.
The 3DSlicer software was used to orient and measure maxillary displacement of the 3D 
surface models in both groups.26 Landmarks were placed to quantify T2-T1 changes: Point 
A (the most anterior point in the convexity of maxilla in the median sagittal plane), centre of 
the clinical crown of the right maxillary permanent central incisor, right and left most 
inferior point of the lower border of the orbits, right and left infraorbital foramen, right and 
left most inferior and posterior point of the zygomas, right and left mesial-buccal cusp of the 
maxillary permanent first molar. For statistical purposes, right and left mean values were 
utilized. The T2-T1 changes in Point A, and zygoma average, orbitale average, and first 
molar average were measured in the antero-posterior, supero-inferior and 3D directions.
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2.3 | Method error
Twenty images of the ZMSs were selected randomly from the total sample and reclassified 
by the same examiner (F.A.) a month later. A 100% intra-examiner agreement was found.
Regarding the reliability of 3D-surface model measurements, 10 randomly selected patients 
were remeasured by the same observer. Intraclass correlation coefficient with a confidence 
level of 95% was performed to assess the reproducibility of the measurements between T1 
and T2. The reliability of the segmentation and superimposition methods has already been 
validated. 26–29
2.4 | Statistical analysis
Chi-square tests with Yates’ correction were used to assess between-group differences in 
gender distribution. The influence of the maturation of ZMSs and the type of therapy 
(BAMP versus RME/FM) on the amount of three-dimensional displacements of the maxilla 
and upper permanent first molars (antero-posterior, supero-inferior and 3D displacement 
measured at Point A, zygoma average, orbitale average and first molar average) was 
evaluated by two-way ANOVA with Holm-Sidak post hoc test for multiple comparisons (P<.
05). The two-way ANOVA was performed on the T2-T1 changes for the three-dimensional 
variables when both normal distribution (Shapiro-Wilk test) and equality of variances 
(Levene’s test) were satisfied.
The power of the study was 0.82 (G*Power),30; it was calculated for two-way ANOVA for 
an effect size f of 0.55 for the three-dimensional displacement of the maxilla24 and a alpha 
value of 0.05. The statistical analyses were performed with statistical software packages 
(SPSS 12, SPSS Inc., Chicago, Illinois, USA; SigmaStat 3.5, Systat software, Point 
Richmond, CA).
3 | RESULTS
The intraclass correlation coefficients (ICC) showed very good intra-examiner agreement 
varying from 0.79 to 1.00 for all measurements. Evaluation of ZMS maturation in both the 
RME/FM and BAMP groups is shown in Table 1. Only three cases (one female and two 
males) of the BAMP group showed the more mature stages D and E. In the statistical 
analysis, we decided to exclude these three cases in order to have two treatment groups that 
were homogenous in terms of ZMS maturation stages. Thus, the BAMP group analysed 
statistically consisted of 19 patients (11 females and eight males).
No significant between-group differences were found in gender distribution (chi-square 
test=1.775; P=.183).
Preliminary evaluation of the data showed that each dependent variable (T2-T1 changes for 
the antero-posterior, supero-inferior and 3D directions of Point A, zygoma average, orbitale 
average and first molar average) was distributed normally (Kolmogorov-Smirnov test) for 
each combination of the groups for the two independent variables (ZMS maturation stage 
and type of therapy). The only exception was 3D direction for the first molars that was not 
distributed normally. For this variable, two-way ANOVA was not performed. Homogeneity 
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of variances for each combination of the groups for the two independent variables also was 
assessed (Levene’s test).
The descriptive data of the T2-T1 changes in the antero-posterior, supero-inferior and 3D 
directions for Point A, zygoma average, orbitale average and first molar average according 
to the different ZMS stages and type of therapy (BAMP and RME/FM) are shown in Tables 
2 and 3, respectively.
The antero-posterior displacement of Point A was influenced significantly by both the 
maturational stage of ZMSs and the type of therapy (Table 4). The forward displacement of 
the maxilla was significantly greater at ZMS maturational stage A and B compared to stage 
C (+1.3 mm and 1.4 mm, respectively). As for the type of therapy, the BAMP group 
demonstrated significantly greater forward displacement of the maxilla (+1.9 mm) compared 
to RME/FM treatment (Table 3). However, the interaction between ZMS maturational stages 
and type of therapy produced no significant effects on the antero-posterior displacement of 
Point A (Table 4).
The supero-inferior displacement of Point A was influenced significantly by the type of 
therapy, with the RME/FM group showing a significantly greater downward displacement of 
Point A than the BAMP group (1.2 mm, Table 4). The 3D displacement of Point A was 
influenced significantly by the type of therapy, with the BAMP group exhibiting a 
significantly greater 3D displacement than the RME/FM group (1.2 mm). As for the average 
antero-posterior displacement of the zygomas, only the type of therapy had a significant 
influence (Table 5). The BAMP group exhibited a significantly greater forward displacement 
of the zygomas than did the RME/FM group (1.0 mm). The 3D displacement of the zygomas 
was influenced significantly by the type of therapy, with the BAMP group presenting a 
significantly greater 3D displacement than the RME/FM group (0.9 mm). No significant 
influence of either type of therapy or maturational stage of ZMSs was assessed for the 
supero-inferior displacement of the zygomas.
The antero-posterior displacement of orbits at orbitale was influenced significantly by the 
type of therapy and by the interaction between ZMS maturational stages and type of 
treatment (Table 6). The BAMP group showed a significantly greater forward displacement 
of the orbits with respect to RME/FM group (1.2 mm). Within both ZMS maturational 
stages A and B, the BAMP group exhibited significantly greater forward displacement of the 
orbits with respect to RME/FM group (2.0 mm and 1.0 mm, respectively). No significant 
difference could be recorded between the 2 types of treatment within ZMS maturational 
stage C. When analysing the influence of the ZMS maturational stages within the BAMP 
group, only patients treated at stage A showed a significantly greater forward displacement 
of the orbits than did patients treated at stage C (1.3 mm).
Within the RME/FM group, the ZMS maturational stages did not influence the amount of 
protraction of the orbits. The 3D displacement of orbitale was influenced significantly by 
both the ZMS maturational stage and the type of therapy. ZMS stage B demonstrated a 
significantly greater 3D displacement of orbitale than ZMS stage C (0.7 mm), while the 
BAMP group showed a significantly greater 3D displacement of orbitale compared to 
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RME/FM group (0.8 mm). No significant influence of either type of therapy or maturational 
stage of ZMSs was assessed for the supero-inferior displacement of the orbits.
The antero-posterior displacement of first molars was influenced significantly by the type of 
therapy, with the BAMP group presenting with a significantly greater forward displacement 
of the first molar than the RME/FM group (1.3 mm - Table 7). No significant influence of 
either type of therapy or maturational stage of ZMSs was assessed for the supero-inferior 
displacement of the first molars.
4 | DISCUSSION
Previous experimental studies on monkeys17,19–21 have shown that the zygomaticomaxillary 
sutures and the pterygopalatine sutures presented similar histological findings, with more 
complexity of interdigitations compared to other circummaxillary sutures. The ZMSs are the 
longest and largest of all circummaxillary sutures.17,18,21 In an earlier study, individual 
assessment of the maturation of the ZMSs was proposed as a possible indicator of the 
response to orthopaedic maxillary protraction in Class III patients.22 Clinically, maxillary 
protraction has been shown to be unpredictable with respect to chronological age at the start 
of treatment.2,8,11,13,24
The present study showed that the stage of ZMS maturation was significantly associated 
with the amount of maxillary protraction. A significantly greater forward displacement of 
the maxilla (measured at Point A) was found when treatment with either BAMP or RME/FM 
was performed at ZMS maturational stages A and B compared to stage C (1.3 mm and 1.4 
mm, respectively; Table 4). There was greater protraction of the orbits at orbitale in the 
BAMP group at ZMS maturational stage A vs stage C (1.3 mm) (Table 6). Stage C 
demonstrated many bony bridges along the ZMS that presumably hampered the forward 
displacement of the maxilla and the orbits in the BAMP group, reflecting less maxillary 
protraction compared to stages A and B for both groups (Figures 1–4).
The type of therapy also influenced the response to maxillary protraction significantly. 
BAMP treatment promoted greater forward displacement of Point A, the zygomas, and the 
orbits than did RME/FM treatment (1.0–1.2 mm, Tables 4–6), corroborating the results of 
Hino et al.24 However, one of the limitation of these previous studies is that displacement 
measurements were made from iterative closest point (ICP). ICP does not distinguish 
between vertical and AP displacement nor does it record displacement of analogous 
landmarks. This study utilizes the methods described by Yatabe et al.29 to measure 3D 
displacements between analogous points and the x, y and z components of these 3D 
distances. It also incorporated standardized reference planes into the registered models. It is 
interesting to note that RME/FM therapy produced significantly greater displacement of 
Point A in a downward direction with respect to the BAMP protocol (1.2 mm; Table 4).
According to chronological age, greater skeletal results would be expected in RME/FM 
patients, because this group was younger than the BAMP group at the start of treatment. 
Usually, BAMP has been recommended during the late mixed dentition or early permanent 
dentition or when the patient has reached 10 years of age31,32 because most of the failures of 
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zygomatic plates occurred in the youngest patients.16 The anchorage of BAMP essentially is 
skeletal and the orthopaedic forces are applied close to the circummaxillary sutures, 
increasing its orthopaedic effects.
Despite the higher force delivered by RME/FM treatment, the force is applied to the 
expander attached to the maxillary teeth dissipating the force to the periodontal ligament 
area.31,33 Probably, because of that, the ZMS maturational stages did not influence the 
quantity of the protraction of the orbits in the RME/FM group (Table 5). In addition, it 
should be noted that the response to maxillary protraction is highly dependent on patient 
cooperation. Patient compliance tends to be lower in patients with a facial mask compared to 
BAMP with Class III elastics.31
While the ZMS maturational stages and type of therapy may influence the amount and/or 
direction of maxillary protraction, the interaction between these factors was not statistically 
significant for the antero-posterior displacement of Point A (Table 4). This finding probably 
can be explained by a significantly greater maxillary protraction with the BAMP protocol 
compared to the RME/FM protocol only in patients at ZMS Stages A or B. No significant 
differences between the two therapies were found in the amount of maxillary protraction for 
patients with ZMS Stage C. On the other hand, there was a significant interaction between 
ZMS maturational stages and type of therapy in the forward displacement of the orbits. The 
BAMP group demonstrated greater forward displacement of the orbits at ZMS maturational 
stages A and B with respect to RME/FM (2.0 mm and 1.0 mm, respectively; Table 6).
The ZMS were evaluated on both sides and, when they presented different maturational 
stages, the more mature stage of ZMSs was considered. One of these cases presented ZMS 
stage B on the right side and A on the left. In this patient, probably the clinical difference in 
response to treatment would be insignificant as the maxillary protraction showed a very 
satisfactory result on both sides. Another patient who presented with ZMS stage B on the 
right side and stage C on the left had a very poor protraction effect of the maxilla. It is 
possible that the ZMS stage C hampered the maxillary protraction on both sides. For these 
cases, we considered the more mature maturational stage of ZMS for the statistical analysis. 
However, future investigations are needed to evaluate the clinical importance of a one-sided 
fusion or more advanced maturational stage of the ZMS.
The CBCT images of three patients showing ZMS maturational stage D (one female and one 
male patient, both 12.5 years of age) or stage E (a 13-year-old male patient) were analysed 
but were removed from the original BAMP sample for statistical reasons. It is interesting to 
note that these patients did not exhibit much maxillary protraction, with both patients at 
stage D presenting an antero-posterior displacement of the maxilla of about −0.5 mm, with 
no sagittal effect at the zygomas and orbits. The main effect was in a vertical direction, with 
an inferior displacement of maxilla of 1.5 mm and 1.7 mm (Figures 5 and 6).
Interestingly, the patient at stage E showed no sagittal or vertical effect in maxilla position 
(−1.2 mm and −0.2 mm, respectively) or the position of the orbits, with only inferior 
displacement of the zygomas (1.6 mm; Figure 7) observed. In this patient, the BAMP 
protocol seemed to produce some vertical skeletal effects while presenting with a more 
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mature ZMS stage. This preliminary finding needs to be confirmed in samples of patients 
with more mature ZMS stages.
This study applied a validated classification of maturation of ZMS to individually assess the 
morphology of this circummaxillary suture prior to orthopaedic maxillary protraction, 
mainly for juvenile and early adolescent patients for whom this treatment still is 
unpredictable. This method potentially can predict a good response from RME/FM 
treatment for patients at stages A or B up to 15 years of age or avoid the failure and side 
effects of the BAMP or RME/FM treatments for younger patients showing fusion of ZMSs. 
However, the sample size for some maturational stages of ZMS was relatively small in the 
present study, and future investigations of stages D and E, in which the ZMSs are fused, may 
further elucidate the clinical responses at each ZMS stage.
Thus, the acquisition of a pre-treatment small field CBCT image including the ZMS region 
may be used as a triage tool for prediction of the orthopaedic result for BAMP and RME/FM 
as well to evaluate bone quality and thickness in the infrazygomatic crest for BAMP 
placement, at a relatively low radiation dose. Future studies, however, would be 
recommended using a larger sample to confirm our results prior the application of the 
present classification method in the clinical practice.
5 | CONCLUSIONS
The early maturational stages of the ZMS are related directly to the greater amount of 
maxillary protraction response resulting from RME/FM or BAMP treatments. Class III 
patients with ZMS stages A and B demonstrated greater maxillary protraction than patients 
at stage C (Point A and orbitale region).
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FIGURE 1. 
Patient with good response from rapid maxillary expansion and facial mask treatment and 
zygomaticomaxillary sutures at stage B. Colour-coded map is used for visualization of the 
maxillary protraction and graphic display of the 3D surface distances in mm [Colour figure 
can be viewed at wileyonlinelibrary.com]
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FIGURE 2. 
Patient in the rapid maxillary expansion and facial mask group who presented poor response 
to maxillary protraction. Note that zygomaticomaxillary sutures were at Stage C. Colour-
coded map is used for visualization purposes and graphic display of the 3D surface distances 
in mm [Colour figure can be viewed at wileyonlinelibrary.com]
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FIGURE 3. 
Patient with zygomaticomaxillary sutures at Stage A and marked response of maxillary and 
zygomatic protraction with bone-anchored maxillary protraction treatment. Colour-coded 
map is used for visualization purposes and graphic display of the 3D surface distances in 
mm [Colour figure can be viewed at wileyonlinelibrary.com]
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FIGURE 4. 
Patient in the bone-anchored maxillary protraction group who presented poor response to 
maxillary protraction. Note that zygomaticomaxillary sutures were at Stage C. Colour-coded 
map is used for visualization purposes and graphic display of the 3D surface distances in 
mm [Colour figure can be viewed at wileyonlinelibrary.com]
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FIGURE 5. 
Patient at Stage D of zygomaticomaxillary sutures maturation, who presented mostly vertical 
response to maxillary protraction with bone-anchored maxillary protraction, as can be seen 
in the semi-transparent overlay in the right. Colour-coded map is used for visualization 
purposes and graphic display of the 3D surface distances in mm. In semi-transparent overlay 
in the right, the time 1 surface model is shown in green and the time 2 is shown in 
transparent white [Colour figure can be viewed at wileyonlinelibrary.com]
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FIGURE 6. 
Boy with zygomaticomaxillary sutures at Stage D demonstrating only little vertical effect 
after bone-anchored maxillary protraction treatment. Colour-coded map is used for 
visualization purposes and graphic display of the 3D surface distances in mm. In semi-
transparent overlay in the right, the time 1 surface model is shown in red and the time 2 is 
shown in transparent white [Colour figure can be viewed at wileyonlinelibrary.com]
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FIGURE 7. 
Patient at Stage E of zygomaticomaxillary sutures maturation, who presented almost no 
response to maxillary protraction with bone-anchored maxillary protraction. Colour-coded 
map is used for visualization purposes and graphic display of the 3D surface distances in 
mm [Colour figure can be viewed at wileyonlinelibrary.com]
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TABLE 3
Descriptive statistics for the three-dimensional T2-T1 changes according to the two treatment protocols (mm)
BAMP group (N=19) RME/FM group (N=18)
Mean SD Mean SD
A point
 A-P 3.1 1.2 1.3 1.2
 S-I 0.6 1.6 1.7 1.0
 3D 3.7 1.2 2.6 0.9
Average zygoma
 A-P 2.1 1.1 1.1 0.8
 S-I 1.2 1.0 1.0 1.0
 3D 2.9 0.9 2.1 0.5
Average orbitale
 A-P 1.6 0.9 0.6 0.6
 S-I 0.3 0.9 0.5 0.9
 3D 2.1 0.8 1.5 0.6
Average first molar
 A-P 3.8 1.5 2.9 2.2
 S-I 2.3 1.2 2.7 1.7
 3D 4.7 1.4 4.9 1.7
SD, Standard deviation; A-P, antero-posterior; S-I,supero-inferior.
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